
AI is Making Drug Discovery Easier
Including AI in Drug discovery can lower the hurdles and challenges which were previously faced by researchers and scientists.
FREMONT, CA: Researchers face slim odds while transforming molecules into medicines. The success rate of drug discovery even on an average scale dangles between a little higher and little lower, causing a sluggish growth in the development of new medicines. With failure rates of drug discovery elevating in the past decade, scientists and researchers have collectively concluded to integrate artificial intelligence (AI) to enhance and enrich the clinical trial process. AI, with its sophisticated computational tools such as molecular dynamics simulation and machine learning, has provided a positive response for creating better medicines.
Back in the day, a drug discovery usually started with basic research to uncover targets that are highly susceptible to infection. Then, the researchers dealt with a high throughput screening process to detect protein affinity. After that, came various complex chemical and biological tests to fine-tune the results, it sounds such an intricate and strenuous process. But including AI in all these steps efficiently will sharpen the effectiveness of each stage.
AI-powered tools are already being utilized in discovering upcoming drugs by clinical researchers. However, it is still to be seen how ready the healthcare sector is for this change.
Top-rate Targeting
AI-powered computational tools are being used to leverage extensive scale data for identifying better novel targets. The ability to harness knowledge and crucial information from genetic data for understanding diseases has been made possible by AI-powered tools.
Unraveling biological information from AI explained why drug trials often failed to succeed in Phase II and III trials. Creating a genotypic and phenotypic flowchart helps scientists to find superior starting targets and reduces the calculative errors.
Data Management
Scientists repeatedly struggle while analyzing patients' data. However, with AI, the analysis of tens and thousands of individual data becomes an easy task to conduct. With machine learning, the researchers can focus on key things that further improve the functionality and efficiency of the clinical drug development process. Analyzing patient's data can detect and even identify the stage of a specific disease. Therefore, efficient data management by AI researchers can trigger perfect immune responses to eliminate the growing threats inside the body.
Check This Out: Top Drug Discovery Companies
ON THE DECK
Featured Vendors
Tenthpin: The Trusted Advisor for Data-Driven Patient- Centric Value Chain Management in Life Sciences
Process Stream: Into the Depths: How Process Stream Leverages Experience and Embedded Research to Transform Businesses from the Inside Out
Indegene: Leveraging Technology to Drive Growth and Productivity Investing In Innovation In Operations, Analytics and Clinical Technology
MMIS: Global Compliance Platform Streamlines Processes and Delivers Business Intelligence Enterprise-Wide
Acceliant: Leading with Innovation, Facilitating Collaboration, Standardization and Productivity in Clinical Trial Management
Saama Technologies: New Fluid Analytics Engine from Saama Cost-Effectively and Rapidly Resolves Complex Data Analytics Challenges for Life Sciences
Iris Interactive Corporation: Boosting Collaboration and Decision Making Processes to Bring Products
Techsol Corporation: Offering Domain Rich, Regulatory Compliant, Accelerated and Cloud Enabled Techn
Solea Software Solutions: Offering Business Intelligence, Analytics, and Portal Services for Flouris
Xybion Corporation: Providing Interconnected Technology Enabled Solutions for Life Sciences, and other Highly Regulated Industries
EDITOR'S PICK
Essential Technology Elements Necessary To Enable...
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
Comparative Data Among Physician Peers
By George Evans, CIO, Singing River Health System
Monitoring Technologies Without Human Intervention
By John Kamin, EVP and CIO, Old National Bancorp
Unlocking the Value of Connected Cars
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
Digital Innovation Giving Rise to New Capabilities
By Gregory Morrison, SVP & CIO, Cox Enterprises
Staying Connected to Organizational Priorities is Vital...
By Alberto Ruocco, CIO, American Electric Power
Comprehensible Distribution of Training and Information...
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
The Current Focus is On Comprehensive Solutions
By Sergey Cherkasov, CIO, PhosAgro
Big Data Analytics and Its Impact on the Supply Chain
By Pascal Becotte, MD-Global Supply Chain Practice for the...
Technology's Impact on Field Services
By Stephen Caulfield, Executive Director, Global Field...
Carmax, the Automobile Business with IT at the Core
By Shamim Mohammad, SVP & CIO, CarMax
The CIO's role in rethinking the scope of EPM for...
By Ronald Seymore, Managing Director, Enterprise Performance...
Driving Insurance Agent Productivity with Mobile and Big...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
Transformative Impact On The IT Landscape
By Jim Whitehurst, CEO, Red Hat
Get Ready for an IT Renaissance: Brought to You by Big...
By Clark Golestani, EVP and CIO, Merck
Four Initiatives Driving ECM Innovation
By Scott Craig, Vice President of Product Marketing, Lexmark...
Technology to Leverage and Enable
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
AI is the New UI-AI + UX + DesignOps
By Amit Bahree, Executive, Global Technology and Innovation,...
Evolving Role of the CIO - Enabling Business Execution...
By Greg Tacchetti, CIO, State Auto Insurance
Read Also
